Media ReleasesOventus Medical

View All Oventus Medical News


Oventus announces Aeroflow agreement to drive uptake of O2Vent technology


Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd (ASX: OVN) is pleased to announce that its Sleep Treatment Platform will be included in a range of OSA treatment solutions being sold by US Durable Medical Equipment (DME) supply business, Aeroflow Healthcare Inc.

Aeroflow Healthcare Inc. is a premier provider of DME and associated services in the US. The Company is on an aggressive growth path, targeting nationwide expansion and has identified OSA therapeutics as a key growth driver for its business. 

For more information, download the attached PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?